Back

Select your region

Corporate

Europe:

Flag Albania Albania Flag Bosnia and Herzegovina Bosnia and Herzegovina Flag Bulgaria Bulgaria Flag Croatia Croatia Flag Cyprus Cyprus Flag Montenegro Montenegro Flag Czech Republic Czech Republic Flag Denmark Denmark Flag Estonia Estonia Flag Spain Spain Flag Kosovo Kosovo Flag Lithuania Lithuania Flag Latvia Latvia Flag Luxembourg Luxembourg Flag Macedonia Macedonia Flag Germany Germany Flag Poland Poland Flag Portugal Portugal Flag Romania Romania Flag Serbia Serbia Flag Slovakia Slovakia Flag Slovenia Slovenia Flag Switzerland Switzerland Flag Sweden Sweden Flag Turkey Turkey Flag Hungary Hungary Flag United Kingdom United Kingdom Flag Italy Italy

Asia:

Flag UAE UAE Flag Hong Kong Hong Kong Flag Kuwait Kuwait Flag Lebanon Lebanon

Africa:

Flag South Africa South Africa

Arrange a consultation about stem cells

Learn more

Get in touch with us today!

Would you like to find out more about our services? Fill out the form below and we will contact you as soon as possible to provide you with all the necessary information and answer your questions.

    We would like to point out that the personal data provided in the form will be processed by FamiCord Suisse, based in Switzerland (BusinessPark Zug Sumpfstrasse 26, 6302 Zug), for the purpose of contacting you by telephone in connection with the provision of service information.

    Image

    List of life saving
    transplantations

    List of uses for stem cells approved by the FamiCord Group’s laboratories:

    Image
    List of uses for stem cells approved by the FamiCord Group’s laboratories:
    Nr. Source Source type Diagnosis Medical sector Year of application Therapy Country Age of the recipient
    1101 Apheresis Allogeneic B-cell Precursor Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy Slovakia 67
    1102 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy USA 72
    1103 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy Italy 52
    1104 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Belgium 64
    1105 Apheresis Allogeneic Myelofibrosis Hematology 2025 Standard Therapy Italy 68
    1106 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy Canada 56
    1107 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy USA 64
    1108 Apheresis Allogeneic Other Myelofibrosis/Myelosclerosis Hematology 2025 Standard Therapy USA 55
    1109 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy USA 64
    1110 Apheresis Allogeneic Myelodysplastic disorder Hematology 2025 Standard Therapy France 63
    1111 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Germany 63
    1112 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy USA 20
    1113 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy France 23
    1114 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy USA 73
    1115 Apheresis Allogeneic Inherited Immune System Disorder Hematology 2025 Standard Therapy France 9
    1116 Apheresis Allogeneic Lymphoma – DLBCL Hematology 2025 Standard Therapy United Kingdom 55
    1117 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Germany 61
    1118 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy Lithuania 58
    1119 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy Germany 73
    1120 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Poland 35
    1121 Apheresis Allogeneic Chronic myelomonocytic leukemia Hematology 2025 Standard Therapy Germany 65
    1122 Apheresis Autologous Multiple myeloma Hematology 2025 Standard Therapy Germany 70
    1123 Apheresis Allogeneic Acute myeloid leukemia Hematology 2025 Standard Therapy Germany 66
    1124 Apheresis Autologous Diffuse large B-cell lymphoma Hematology 2025 Standard Therapy Germany 42
    1125 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Netherlands 65
    1126 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy USA 60
    1127 Apheresis Allogeneic Post Mielofibrosis Hematology 2025 Standard Therapy Poland 66
    1128 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy USA 74
    1129 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Poland 17
    1130 Apheresis Allogeneic Chronic Myelomonocytic Leukemia Hematology 2025 Standard Therapy USA 72
    1131 Apheresis Allogeneic T-cell prolymphocytic leukemia Hematology 2025 Standard Therapy New Zealand 64
    1132 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Germany 62
    1133 Apheresis Allogeneic Mielofibrosis Hematology 2025 Standard Therapy Finland 68
    1134 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Poland 35
    1135 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy USA 34
    1136 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Belgium 63
    1137 Apheresis Allogeneic Mielodysplastic Syndrome Hematology 2025 Standard Therapy Poland 72
    1138 Apheresis Allogeneic Mielodysplastic Syndrome Hematology 2025 Standard Therapy Switzerland 69
    1139 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Poland 52
    1140 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy United Kingdom 26
    1141 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Germany 50
    1142 Apheresis Allogeneic Chronic Lymphocyte Leukemia Hematology 2025 Standard Therapy Poland 71
    1143 Apheresis Allogeneic Anaplastic Large Cell Lymphoma Hematology 2025 Standard Therapy Germany 3
    1144 Apheresis Allogeneic Chronic Myelomonocytic Leukemia Hematology 2025 Standard Therapy USA 71
    1145 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy USA 29
    1146 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Ukraine 38
    1147 Apheresis Allogeneic Chronic Myelomonocytic Leukemia Hematology 2025 Standard Therapy Poland 28
    1148 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Poland 46
    1149 Apheresis Allogeneic Hodking lymphoma Hematology 2025 Standard Therapy Spain 28
    1150 Apheresis Allogeneic Mielodysplastic Syndrome Hematology 2025 Standard Therapy Slovakia 52
    1151 Apheresis Allogeneic T-NHL Angioimmunoblastic T-cell Lymphoma Hematology 2025 Standard Therapy Germany 56
    1152 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy USA 71
    1153 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Italy 23
    1154 Apheresis Allogeneic Mielodysplastic syndrome Hematology 2025 Standard Therapy Spain 69
    1155 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy Brazil 71
    1156 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy United Kingdom 36
    1157 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy Germany 58
    1158 Apheresis Allogeneic Mielodysplastic Syndrome Hematology 2025 Standard Therapy Germany 68
    1159 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy USA 61
    1160 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy USA 35
    1161 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy USA 39
    1162 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Serbia 58
    1163 Apheresis Allogeneic Hodgkin Lymphoma Hematology 2025 Standard Therapy USA 47
    1164 Apheresis Allogeneic Mielodysplastic Syndrome Hematology 2025 Standard Therapy Netherlands 62
    1165 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy USA 69
    1166 Apheresis Allogeneic T-cell Lymphoma Hematology 2025 Standard Therapy United Kingdom 35
    1167 Apheresis Autologous Central Nervous System Lymphoma Hematology 2025 Standard Therapy Germany 71
    1168 Apheresis Allogeneic Acute myeloid leukemia Hematology 2025 Standard Therapy Germany 70
    1169 Apheresis Autologous Multiple myeloma Hematology 2025 Standard Therapy Germany 61
    1170 Apheresis Autologous Multiple myeloma Hematology 2025 Standard Therapy Germany 71
    1171 Apheresis Autologous T-cell lymphoma Hematology 2025 Standard Therapy Germany 39
    1172 Apheresis Autologous Primary central nervous system lymphoma Hematology 2025 Standard Therapy Germany 64
    1173 Apheresis Allogeneic Myelodysplastic syndrome Hematology 2025 Standard Therapy Germany 56
    1174 Apheresis Autologous Multiple myeloma Hematology 2025 Standard Therapy Germany 65
    1175 Apheresis Allogeneic Myelofibrosis Hematology 2025 Standard Therapy Germany 65
    1176 Apheresis Allogeneic Acute myeloid leukemia Hematology 2025 Standard Therapy Germany 60
    1177 Apheresis Autologous Hodgkin lymphoma Hematology 2025 Standard Therapy Germany 32
    1178 Apheresis Allogeneic Myelodysplastic syndrome Hematology 2025 Standard Therapy Germany 67
    1179 Apheresis Autologous Multiple myeloma Hematology 2025 Standard Therapy Germany 56
    1180 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Columbia 62
    1181 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy USA 46
    1182 Apheresis Allogeneic Mielodysplastic Syndrome Hematology 2025 Standard Therapy USA 66
    1183 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy Poland 46
    1184 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy United Kingdom 33
    1185 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy France 31
    1186 Apheresis Allogeneic B-Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy Germany 62
    1187 Apheresis Allogeneic B-Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy USA 62
    1188 Apheresis Allogeneic Hemophagocytic lymphohistiocytosis Hematology 2025 Standard Therapy Czechia 27
    1189 Apheresis Allogeneic Shwachman-Diamond Syndrome Hematology 2025 Standard Therapy Spain 11
    1190 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy Poland 67
    1191 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Canada 60
    1192 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy CROATIA 43
    1193 Apheresis Allogeneic Chronic Myelomonocytic Leukemia Hematology 2025 Standard Therapy USA 69
    1194 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Austria 61
    1195 Apheresis Allogeneic Other Immune System Hematology 2025 Standard Therapy USA 62
    1196 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy USA 74
    1197 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy Poland 63
    1198 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy USA 66
    1199 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy Denmark 50
    1200 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Germany 62